STIMVAX Trademark

Trademark Overview

On Thursday, April 25, 2019, a trademark application was filed for STIMVAX with the United States Patent and Trademark Office. The USPTO has given the STIMVAX trademark a serial number of 88401890. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 12, 2024. This trademark is owned by Immunovative Therapies Ltd.. The STIMVAX trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment of proliferative and metastatic diseases

Medical services for treatment of proliferative and metastatic diseases
stimvax

General Information

Serial Number88401890
Word MarkSTIMVAX
Filing DateThursday, April 25, 2019
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of proliferative and metastatic diseases
Goods and ServicesMedical services for treatment of proliferative and metastatic diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 16, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 16, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMIRROR BIOLOGICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWesley Chapel, FL 33544
Party NameMIRROR BIOLOGICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressLUTZ, FL 33558
Party NameImmunovative Therapies Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMalcha Technology Park 96951
IL

Trademark Events

Event DateEvent Description
Wednesday, March 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 13, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 13, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, February 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 5, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 5, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 5, 2024ASSIGNED TO LIE
Tuesday, May 23, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, March 27, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, March 27, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, December 30, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, December 30, 2022INQUIRY TO SUSPENSION E-MAILED
Friday, December 30, 2022SUSPENSION INQUIRY WRITTEN
Friday, November 18, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, April 7, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, April 7, 2022LETTER OF SUSPENSION E-MAILED
Thursday, April 7, 2022SUSPENSION LETTER WRITTEN
Wednesday, April 6, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 6, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 30, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, October 20, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, October 4, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, October 4, 2021INQUIRY TO SUSPENSION E-MAILED
Monday, October 4, 2021SUSPENSION INQUIRY WRITTEN
Monday, September 27, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, March 5, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, March 5, 2021LETTER OF SUSPENSION E-MAILED
Friday, March 5, 2021SUSPENSION LETTER WRITTEN
Friday, March 5, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 5, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 3, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, September 9, 2020NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, September 9, 2020INQUIRY TO SUSPENSION E-MAILED
Wednesday, September 9, 2020SUSPENSION INQUIRY WRITTEN
Thursday, August 20, 2020SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, August 19, 2020ASSIGNED TO LIE
Monday, January 20, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 21, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 21, 2020LETTER OF SUSPENSION E-MAILED
Tuesday, January 21, 2020SUSPENSION LETTER WRITTEN
Friday, January 17, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 17, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 17, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 17, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 17, 2019NON-FINAL ACTION E-MAILED
Wednesday, July 17, 2019NON-FINAL ACTION WRITTEN
Monday, July 8, 2019ASSIGNED TO EXAMINER
Thursday, May 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 29, 2019NEW APPLICATION ENTERED

Related Keywords

stimvax diseases metastatic proliferative treatment services medical preparations pharmaceutical